Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry

Breast Cancer Research and Treatment

Volumn 128, Issue 2, 2011, Pages 573-579

  Grana B ^a,h   Fachal, L ^b   Darder, E ^c   Balmana J ^a   Ramon Y Cajal T ^d   Blanco, I ^e   Torres, A ^f   Lazaro C ^e   Diez, O ^a   Alonso, C ^d   Santamarina M ^g   Velasco, A ^c   Teule A ^e   Lasa, A ^d   Blanco, A ^b   Izquierdo, A ^c   Borras J ^f   Gutierrez Enriquez S ^a   Vega, A ^b   Brunet, J ^c  

^a VALL D HEBRON UNIVERSITY HOSPITAL   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c HOSPITAL JOSEP TRUETA   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e HOSPITAL DURAN I REYNALS   (Spain)

^f HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^g UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^h Universidad de La Coruña   (Spain)

Author keywords

Ataxia telangiectasia; ATM; BRCA1; BRCA2; Case control study; Hereditary breast cancer; MALDI TOF mass spectrometry

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; ATM GENE; BREAST CANCER; CANCER RESEARCH; CASE CONTROL STUDY; CONTROLLED STUDY; GENE; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GERM LINE; HEREDITY; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; SPAIN; TUMOR SUPPRESSOR GENE;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; DNA; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; MALE; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR SUPPRESSOR PROTEINS;

EID: 79959724603     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1462-x     Document Type: Article

References (34)

1. EB Claus JM Schildkraut WD Thompson NJ Risch 1996 The genetic attributable risk of breast and ovarian cancer Cancer 77 11 2318 2324 8635102 10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z 1:STN:280:DyaK283isV2jsg%3D%3D (Pubitemid 26162426)
2. MR Stratton N Rahman 2008 The emerging landscape of breast cancer susceptibility Nat Genet 40 1 17 22 18163131 10.1038/ng.2007.53 1:CAS:528:DC%2BD1cXhtVyrsQ%3D%3D
3. Anglian Breast Cancer Study Group 2000 Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases Br J Cancer 83 10 1301 1308 10.1054/bjoc.2000.1407
4. A Meindl H Hellebrand C Wiek V Erven B Wappenschmidt D Niederacher M Freund P Lichtner L Hartmann H Schaal, et al. 2010 Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene Nat Genet 42 5 410 414 20400964 10.1038/ng.569 1:CAS:528: DC%2BC3cXkvVCjtbo%3D
5. SL Arcand CM Maugard P Ghadirian A Robidoux C Perret P Zhang E Fafard AM Mes-Masson WD Foulkes D Provencher SA Narod PN Tonin 2008 Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families Breast Cancer Res Treat 108 3 399 408 17541742 10.1007/s10549-007-9608- 6 1:CAS:528:DC%2BD1cXjsFGisLY%3D (Pubitemid 351431072)
6. S Shiovitz J Everett SC Huang MS Orloff C Eng SB Gruber 2010 Head circumference in the clinical detection of PTEN hamartoma tumor syndrome in a clinic population at high-risk of breast cancer Breast Cancer Res Treat 124 2 459 465 20349131 10.1007/s10549-010-0839-6
7. C Turnbull S Ahmed J Morrison D Pernet A Renwick M Maranian S Seal M Ghoussaini S Hines CS Healey, et al. 2010 Genome-wide association study identifies five new breast cancer susceptibility loci Nat Genet 42 6 504 507 20453838 10.1038/ng.586 1:CAS:528:DC%2BC3cXlslyqsro%3D
8. A Hollestelle M Wasielewski JW Martens M Schutte 2010 Discovering moderate-risk breast cancer susceptibility genes Curr Opin Genet Dev 20 3 268 276 20346647 10.1016/j.gde.2010.02.009 1:CAS:528:DC%2BC3cXntlCru74%3D
9. J Prokopcova Z Kleibl CM Banwell P Pohlreich 2007 The role of ATM in breast cancer development Breast Cancer Res Treat 104 2 121 128 17061036 10.1007/s10549-006-9406-6 1:CAS:528:DC%2BD2sXnvFKmsr4%3D (Pubitemid 47084227)
10. PJ McKinnon 2004 ATM and ataxia telangiectasia EMBO Rep 5 8 772 776 15289825 10.1038/sj.embor.7400210 1:CAS:528:DC%2BD2cXmtFOhurg%3D (Pubitemid 39199165)
11. J Hall 2005 The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants Cancer Lett 227 2 105 114 16112413 10.1016/j.canlet.2004.12.001 1:CAS:528:DC%2BD2MXosVaju7o%3D (Pubitemid 41169924)
12. M Swift L Sholman M Perry C Chase 1976 Malignant neoplasms in the families of patients with ataxia-telangiectasia Cancer Res 36 1 209 215 1248000 1:STN:280:DyaE287hs1Whtw%3D%3D
13. M Swift PJ Reitnauer D Morrell CL Chase 1987 Breast and other cancers in families with ataxia-telangiectasia N Engl J Med 316 21 1289 1294 3574400 10.1056/NEJM198705213162101 1:STN:280:DyaL2s3gtFOltQ%3D%3D (Pubitemid 17084026)
14. YR Thorstenson A Roxas R Kroiss MA Jenkins KM Yu T Bachrich D Muhr TL Wayne G Chu RW Davis TM Wagner PJ Oefner 2003 Contributions of ATM mutations to familial breast and ovarian cancer Cancer Res 63 12 3325 3333 12810666 1:CAS:528:DC%2BD3sXks1ehsr0%3D (Pubitemid 36735890)
15. D Thompson S Duedal J Kirner L McGuffog J Last A Reiman P Byrd M Taylor DF Easton 2005 Cancer risks and mortality in heterozygous ATM mutation carriers J Natl Cancer Inst 97 11 813 822 15928302 10.1093/jnci/dji141 1:CAS:528:DC%2BD2MXkvVShtbc%3D (Pubitemid 40909124)
16. A Renwick D Thompson S Seal P Kelly T Chagtai M Ahmed B North H Jayatilake R Barfoot K Spanova L McGuffog DG Evans D Eccles DF Easton MR Stratton N Rahman 2006 ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles Nat Genet 38 8 873 875 16832357 10.1038/ng1837 1:CAS:528:DC%2BD28XnsVChu7Y%3D (Pubitemid 44141653)
17. J Brunet S Gutierrez-Enriquez A Torres V Berez S Sanjose J Galceran A Izquierdo JA Menendez J Guma J Borras 2008 ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations Clin Genet 73 5 465 473 18384426 10.1111/j.1399-0004.2008.00987.x 1:STN:280: DC%2BD1c3jvFyqsA%3D%3D (Pubitemid 351517261)
18. M Mitui C Campbell G Coutinho X Sun CH Lai Y Thorstenson S Castellvi-Bel L Fernandez E Monros BT Carvalho O Porras G Fontan RA Gatti 2003 Independent mutational events are rare in the ATM gene: haplotype prescreening enhances mutation detection rate Hum Mutat 22 1 43 50 12815592 10.1002/humu.10232 1:CAS:528:DC%2BD3sXmtVanur0%3D (Pubitemid 36807771)
19. M Telatar S Wang S Castellvi-Bel LQ Tai S Sheikhavandi JR Regueiro O Porras RA Gatti 1998 A model for ATM heterozygote identification in a large population: four founder-effect ATM mutations identify most of Costa Rican patients with ataxia telangiectasia Mol Genet Metab 64 1 36 43 9682216 10.1006/mgme.1998.2693 1:CAS:528:DyaK1cXkvVKms78%3D (Pubitemid 28453316)
20. S Castellvi-Bel S Sheikhavandi M Telatar LQ Tai M Hwang Z Wang Z Yang R Cheng RA Gatti 1999 New mutations, polymorphisms, and rare variants in the ATM gene detected by a novel SSCP strategy Hum Mutat 14 2 156 162 10425038 10.1002/(SICI)1098-1004(1999)14:2<156::AID-HUMU7>3.0.CO;2-E 1:CAS:528:DyaK1MXltlejt7w%3D (Pubitemid 29372782)
21. N Bogdanova C Cybulski M Bermisheva I Datsyuk P Yamini P Hillemanns NN Antonenkova E Khusnutdinova J Lubinski T Dork 2009 A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer Breast Cancer Res Treat 118 1 207 211 18807267 10.1007/s10549-008-0189-9 1:CAS:528:DC%2BD1MXht1GmtbfP
22. A Blanco B Grana L Fachal M Santamarina J Cameselle-Teijeiro C Ruiz-Ponte A Carracedo A Vega 2010 Beyond BRCA1 and BRCA2 wild-type breast and/or ovarian cancer families: germline mutations in TP53 and PTEN Clin Genet 77 2 193 196 19930417 10.1111/j.1399-0004.2009.01309.x 1:CAS:528:DC%2BC3cXitF2jtrw%3D
23. MA Garcia-Perez LM Allende A Corell P Varela AA Moreno A Sotoca A Moreno E Paz-Artal E Barreiro A Arnaiz-Villena 2001 Novel mutations and defective protein kinase C activation of T-lymphocytes in ataxia telangiectasia Clin Exp Immunol 123 3 472 480 11298136 10.1046/j.1365-2249.2001.01452.x 1:CAS:528:DC%2BD3MXjtFyjtrg%3D (Pubitemid 32289968)
24. J Brunet 2010 Hereditary breast cancer and genetic counseling in young women Breast Cancer Res Treat 123 Suppl 1 7 9 20711663 10.1007/s10549-010-1050-5
25. M Ahmed N Rahman 2006 ATM and breast cancer susceptibility Oncogene 25 43 5906 5911 16998505 10.1038/sj.onc.1209873 1:CAS:528:DC%2BD28XhtVSgurvF (Pubitemid 44453446)
26. O Fletcher N Johnson I dos Santos Silva N Orr A Ashworth H Nevanlinna T Heikkinen K Aittomaki C Blomqvist, et al. 2010 Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls Cancer Epidemiol Biomarkers Prev 19 9 2143 2151 20826828 10.1158/1055-9965.EPI-10-0374 1:CAS:528: DC%2BC3cXhtFartrfM
27. SV Tavtigian PJ Oefner D Babikyan A Hartmann S Healey F Le Calvez-Kelm F Lesueur GB Byrnes SC Chuang N Forey, et al. 2009 Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer Am J Hum Genet 85 4 427 446 19781682 10.1016/j.ajhg.2009.08.018 1:CAS:528: DC%2BD1MXhsFWht7nP
28. JL Bernstein RW Haile M Stovall JD Boice RE Shore B Langholz DC Thomas L Bernstein CF Lynch JH Olsen, et al. 2010 Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study J Natl Cancer Inst 102 7 475 483 20305132 10.1093/jnci/djq055 1:CAS:528:DC%2BC3cXks1Ggtrc%3D
29. KC Drumea E Levine J Bernstein B Shank S Green E Kaplan L Mandell J Cropley J Obropta I Braccia A Krupnik BS Rosenstein 2000 ATM heterozygosity and breast cancer: screening of 37 breast cancer patients for ATM mutations using a non-isotopic RNase cleavage-based assay Breast Cancer Res Treat 61 1 79 85 10930092 10.1023/A:1006463730337 1:CAS:528:DC%2BD3cXlslaqsLs%3D (Pubitemid 30440552)
30. A Broeks LM Braaf A Huseinovic MK Schmidt NS Russell FE van Leeuwen FB Hogervorst LJ Van 't Veer 2008 The spectrum of ATM missense variants and their contribution to contralateral breast cancer Breast Cancer Res Treat 107 2 243 248 17393301 10.1007/s10549-007-9543-6 1:CAS:528:DC%2BD2sXhsVarurrN (Pubitemid 350265692)
31. T Tapia A Sanchez M Vallejos C Alvarez M Moraga S Smalley M Camus M Alvarez P Carvallo 2008 ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences? Breast Cancer Res Treat 107 2 281 288 17351744 10.1007/s10549-007-9544-5 1:CAS:528: DC%2BD2sXhsVarurrP (Pubitemid 350265693)
32. AE Hirsch DP Atencio BS Rosenstein 2008 Screening for ATM sequence alterations in African-American women diagnosed with breast cancer Breast Cancer Res Treat 107 1 139 144 17333338 10.1007/s10549-007-9531-x 1:CAS:528: DC%2BD2sXhtlGrtb3O (Pubitemid 350179591)
33. LL Paglia A Lauge J Weber J Champ E Cavaciuti A Russo JL Viovy D Stoppa-Lyonnet 2010 ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy Breast Cancer Res Treat 119 2 443 452 19404735 10.1007/s10549-009-0396-z
34. T Walsh MK Lee S Casadei AM Thornton SM Stray C Pennil AS Nord JB Mandell EM Swisher MC King 2010 Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing Proc Natl Acad Sci USA 107 28 12629 12633 20616022 10.1073/pnas.1007983107 1:CAS:528: DC%2BC3cXpt1ehsr0%3D